Argenx
ARGX
$923.61
Share price
-2.94%
Change (1 day)
59.79%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Argenx (ARGX) - Net assets
Net assets on the balance sheet as of December 2024 : A$8.64 Billion
According to Argenx
's latest financial reports the company has A$8.64 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Argenx - Net assets on balance sheet (from 2021 to 2020)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $A$8.83 B | 46.98% |
| 2023-12-31 | $A$6.01 B | 45.46% |
| 2022-12-31 | $A$4.13 B | 18.28% |
| 2021-12-31 | $A$3.49 B | 30.54% |
| 2020-12-31 | $A$2.67 B | 41.78% |
| 2019-12-31 | $A$1.88 B | 88.84% |
| 2018-12-31 | $A$1.00 B | 57.25% |
| 2017-12-31 | $A$0.63 B | 553.91% |
| 2016-12-31 | $A$97.25 M | 58.99% |
| 2015-12-31 | $A$61.17 M | -32.41% |
| 2014-12-31 | $A$90.5 M | 95.03% |
| 2013-12-31 | $A$46.4 M | 118.93% |
| 2012-12-31 | $A$21.19 M | -40.02% |
| 2011-12-31 | $A$35.33 M | 163.71% |
| 2010-12-31 | $A$13.39 M |